Pregnancy and primary Sjögren’s syndrome: management and outcomes in a multicentre retrospective study of 54 pregnancies

References

• Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y. Sjögren’s syndrome, the old and the new. New Pearls CTDs 2012;26:105–17.
   Google Scholar
• Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjögren’s syndrome. Autoimmun Rev 2010;9:A305–10.
   PubMed Web of Science ®Google Scholar
• Morel N, Georgin-Lavialle S, Levesque K, Guettrot-Imbert G, Le Guern V, Le Bidois J, et al. Neonatal lupus syndrome: Literature review. Rev Med Interne 2015;36:159–66.
   PubMed Web of Science ®Google Scholar
• Izmirly PM, Saxena A, Kim MY, Wang D, Sahl SK, Llanos C, et al. Maternal and fetal factors associated with mortality and morbidity in a multi–racial/ethnic registry of anti-ssa/ro–associated cardiac neonatal lupus. Circulation 2011;124:1927–35.
   PubMed Web of Science ®Google Scholar
• Monsarrat N, Houfflin-Debarge V, Richard A, Launay D, Lambert M, Hatron P-Y, et al. Fetal ultrasonography and doppler in isolated congenital heart block. Gynecol Obstet Fertil 2009;37:633–44.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61:554–8.
   PubMed Web of Science ®Google Scholar
• Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, Khamashta MA, Kim MY, Saxena A, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-ssa/ro-antibody–associated cardiac manifestations of neonatal lupus. Circulation 2012;126:76–82.
   PubMed Web of Science ®Google Scholar
• Izmirly PM, Kim MY, Llanos C, Le PU, Guerra MM, Askanase AD, et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 2010;69:1827–30.
   PubMed Web of Science ®Google Scholar
• Julkunen H, Kaaja R, Kurki P, Palosuo T, Friman C. Fetal outcome in women with primary Sjögren’s syndrome. A retrospective case-control study. Clin Exp Rheumatol 1995;13:65–71.
   PubMed Web of Science ®Google Scholar
• Skopouli FN, Papanikolaou S, Malamou-Mitsi V, Papanikolaou N, Moutsopoulos HM. Obstetric and gynaecological profile in patients with primary Sjögren’s syndrome. Ann Rheum Dis 1994;53:569–73.
   PubMed Web of Science ®Google Scholar
• De Carolis S, Salvi S, Botta A, Garofalo S, Garufi C, Ferrazzani S, et al. The impact of primary Sjogren’s syndrome on pregnancy outcome: our series and review of the literature. Autoimmun Rev 2014;13:103–7.
   PubMed Web of Science ®Google Scholar
• Hussein SZ, Jacobsson LTH, Lindquist PG, Theander E. Pregnancy and fetal outcome in women with primary Sjogren’s syndrome compared with women in the general population: a nested case-control study. Rheumatology (Oxford) 2011;50:1612–17.
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Thromb Haemost 2006;4:295–306.
   Web of Science ®Google Scholar
• Lemery D, Legendre G, Huchon C, Perrier I, Deffieux X. Guidelines for clinical practice: « Pregnancy losses ». Introduction and legislation. J Gynecol Obstet Biol Reprod (Paris) 2014;43:748–52.
   PubMed Web of Science ®Google Scholar
• Vendittelli F, Rivière O, Crenn-Hébert C, Claris O, Tessier V, Pinquier D, et al. Audipog perinatal network. Part 1: Principal Perinatal Health Indicators, 2004-2005. Gynecol Obstet Fertil. 2008;36:1091–100.
   PubMed Web of Science ®Google Scholar
• Martel C, Gondran G, Launay D, Lalloué F, Palat S, Lambert M, et al. Active immunological profile is associated with systemic Sjögren’s syndrome. J Clin Immunol 2011;31:840–7.
   PubMed Web of Science ®Google Scholar
• Siamopoulou-Mavridou A, Manoussakis MN, Mavridis AK, Moutsopoulos HM. Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset. Ann Rheum Dis 1988;47:982–7.
   PubMed Web of Science ®Google Scholar
• Takaya M, Ichikawa Y, Shimizu H, Uchiyama M, Moriuchi J, Arimori S. Sjögren’s syndrome and pregnancy. Tokai J Exp Clin Med 1991;16:83–8.
   PubMedGoogle Scholar
• Haga H-J, Gjesdal CG, Koksvik HS, Skomsvoll JF, Irgens LM, Ostensen M. Pregnancy outcome in patients with primary Sjögren’s syndrome. A case-control study. J Rheumatol 2005;32:1734–6.
   PubMed Web of Science ®Google Scholar
• Priori R, Gattamelata A, Modesti M, Colafrancesco S, Frisenda S, Minniti A, et al. Outcome of pregnancy in Italian patients with primary Sjögren syndrome. J Rheumatol 2013;40:1143–7.
   PubMed Web of Science ®Google Scholar
• Paré E, Parry S, Mcelrath TF, Pucci D, Newton A, Lim K-H. Clinical risk factors for preeclampsia in the 21st century. Obstet Gynecol 2014;124:763–70.
   PubMed Web of Science ®Google Scholar
• Reichman NE, Pagnini DL. Maternal age and birth outcomes: data from New Jersey. Fam Plann Perspect 1997;29:268–72,295.
   PubMedGoogle Scholar
• Simpson JL. Incidence and timing of pregnancy losses: relevance to evaluating safety of early prenatal diagnosis. Am J Med Genet 1990;35:165–73.
   PubMed Web of Science ®Google Scholar
• Wilcox AJ, Weinberg CR, O’Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med 1988;319:189–94.
   PubMed Web of Science ®Google Scholar
• Rai R, Regan L. Recurrent miscarriage. Lancet 2006;368:601–11.
   PubMed Web of Science ®Google Scholar
• Marchetti T, Ruffatti A, Wuillemin C, De Moerloose P, Cohen M. Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies. J Thromb Haemost 2014;12:910–20.
   PubMed Web of Science ®Google Scholar
• Cervera R, García-Carrasco M, Font J, Ramos M, Reverter JC, Muñoz FJ, et al. Antiphospholipid antibodies in primary Sjögren’s syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 1997;15:361–5.
   PubMed Web of Science ®Google Scholar
• Fauchais AL, Lambert M, Launay D, Michon-Pasturel U, Queyrel V, Nguyen N, et al. Antiphospholipid antibodies in primary Sjögren’s syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 2004;13:245–8.
   PubMed Web of Science ®Google Scholar
• Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur J Endocrinol 2004;150:751–5.
   PubMed Web of Science ®Google Scholar
• Lee YL, Ng HP, Lau KS, Liu WM, Yeung WSB, et al. Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model. Fertil Steril 2009;91:2104–9.
   PubMed Web of Science ®Google Scholar
• Blondel B, Lelong N, Kermarrec M, Goffinet F. [Trends in perinatal health in France between 1995 and 2010: results from the National Perinatal surveys]. J Gynecol Obstet Biol Reprod (Paris) 2012;41:151–66.
   PubMed Web of Science ®Google Scholar
• Goffinet F, Humbert R, Clerson P, Philippe HJ, Bréart G, Cabrol D. National survey on the use of induced labor by obstetricians. Study group on induced labor. J Gynecol Obstet Biol Reprod (Paris) 1999;28:319–29.
   PubMedGoogle Scholar
• Goffinet F, Dreyfus M, Carbonne B, Magnin G, Cabrol D. Survey of the practice of cervical ripening and labor induction in France. J Gynecol Obstet Biol Reprod (Paris) 2003;32:638–46.
   PubMedGoogle Scholar
• Peltoniemi OM, Kari MA, Hallman M. Repeated antenatal corticosteroid treatment: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2011;90:719–27.
   PubMed Web of Science ®Google Scholar
• Zupan Simunek V. Definition of intrapartum asphyxia and effects on outcome. J Gynecol Obstet Biol Reprod (Paris) 2008;37 (Suppl 1):S7–15.
   Google Scholar
• Hernández-Molina G, Leal-Alegre G, Michel-Peregrina M. The meaning of anti-Ro and anti-La antibodies in primary Sjögren’s syndrome. Autoimmun Rev 2011;10:123–5.
   PubMed Web of Science ®Google Scholar
• Theander E, Brucato A, Gudmundsson S, Salomonsson S, Wahren-Herlenius M, Manthorpe R. Primary Sjögren’s syndrome–treatment of fetal incomplete atrioventricular block with dexamethasone. J Rheumatol 2001;28:373–6.
   PubMed Web of Science ®Google Scholar